Peptide therapy is one of the fastest-growing opportunities in cash-pay medicine. Patient demand for physician-supervised wellness programs, growth hormone optimization, cellular health, metabolic support, and hormone therapy, continues to grow as awareness expands and more patients seek alternatives to conventional insurance-based care.
This guide covers everything a medical practice needs to know to start offering peptide therapy: choosing the right compounds and pharmacy partners, building clinical workflows, and marketing your program to patients.
Why Peptide Therapy Is an Opportunity Right Now
Three forces are converging to make 2026 the optimal time for practices to launch peptide programs.
Growing patient demand. Patient awareness of peptide therapy has grown significantly through functional medicine, anti-aging, and wellness communities. Patients arrive already researching these options and are actively looking for a physician-supervised source they can trust.
GLP-1 compounding restrictions create diversification urgency. The FDA ended the semaglutide shortage in February 2025 and is restricting compounded GLP-1 medications. Practices dependent on compounded semaglutide or tirzepatide need additional revenue streams. Peptide therapy provides a complementary cash-pay program that broadens your offering across multiple patient needs.
Cash-pay economics. Peptide therapy programs operate entirely outside insurance. No claim denials, no prior authorizations, no reimbursement delays. Practices typically purchase compounded peptides at wholesale pricing from their pharmacy partner and set their own patient pricing.
The Economics
A single peptide therapy patient on a monthly protocol generates recurring revenue. Practices offering multiple peptides across therapeutic categories (performance, immune support, body composition, hormone optimization) can serve a wide range of patient needs from the same program infrastructure.
Which Peptides Practices Are Offering
The most commonly prescribed compounds fall into several therapeutic categories. Confirm current FDA category status with your pharmacy partner before prescribing any compound.
Performance and Body Composition
Sermorelin is a growth hormone-releasing hormone analog that stimulates the pituitary to produce GH naturally. It is one of the most widely requested peptides for body composition, recovery, sleep quality, and general wellness in active adults. It has an established safety profile and is a natural starting point for most peptide programs.
Cellular Health and Energy
NAD+ (nicotinamide adenine dinucleotide) supports mitochondrial energy production and cellular repair. Injectable NAD+ protocols deliver significantly higher bioavailability than oral supplementation. They are popular with longevity-focused, biohacking, and high-performance patient populations.
Antioxidant and Recovery Support
Glutathione is the body’s primary antioxidant. Physician-supervised injectable Glutathione protocols support oxidative stress reduction, recovery, and systemic wellness. They are particularly relevant for patients under high physical or metabolic stress.
Weight Management
Compounded semaglutide and compounded tirzepatide remain high-demand programs where compounding is permitted. Verify current FDA shortage and compounding eligibility status before prescribing. See GLP-1 compounding regulations 2026 for current guidance.
Hormone Optimization
Testosterone replacement therapy for men with clinically low testosterone and hormone replacement therapy for women are established, high-retention cash-pay programs that pair naturally with peptide protocols.
PT-141 (Bremelanotide) is an FDA-approved medication for hypoactive sexual desire disorder in women and is used off-label for sexual dysfunction in men. It is a strong addition for practices serving a sexual wellness or hormone-focused patient population.
Choosing a Compounding Pharmacy Partner
Your pharmacy partner is one of the most critical decisions for a peptide therapy program. The right partner ensures reliable supply, competitive pricing, quality assurance, and smooth fulfillment.
Key Evaluation Criteria
Peptide formulary breadth. Does the pharmacy carry the specific peptides you want to prescribe? Some pharmacies have extensive peptide formularies while others focus on a narrower selection. Make sure your priority peptides are available.
503A vs. 503B pathway. 503A pharmacies compound patient-specific prescriptions based on individual orders. 503B outsourcing facilities can compound in larger batches. Both pathways are used for peptide therapy. Consider which aligns with your prescribing volume and workflow.
Fulfillment model. Some pharmacies ship directly to patients. Others ship to the practice for dispensing. Direct-to-patient fulfillment is more convenient and reduces practice overhead. Make sure the model works for your operations.
Quality and accreditation. Look for pharmacies with PCAB accreditation, proper state licensing, and documented quality testing protocols. For peptides, third-party potency and purity testing is especially important.
Integration capabilities. Can you send prescriptions electronically with minimal manual work? Platforms like Karpa Health integrate directly with multiple pharmacies for one-click prescribing, eliminating manual faxing or portal entry.
Setting Up Patient Intake and Clinical Workflows
A well-structured workflow is what separates a profitable peptide program from a chaotic one. Here is what you need to build:
Patient Intake
Your intake process should capture everything the prescribing physician needs to make a clinical decision:
- Medical history including current conditions, past surgeries, and hospitalizations
- Current medications to screen for drug interactions
- Allergies including any history of reaction to injectable medications
- Treatment goals so the physician understands what the patient is looking for
- Contraindication screening questions specific to peptide therapy (pregnancy, active cancer, bleeding disorders)
- Informed consent covering the off-label nature of many peptide applications, potential side effects, and the patient’s right to decline
Intake forms should be digital, HIPAA-compliant, and ideally embedded on your practice’s website under your brand. This creates a smooth patient experience and keeps the workflow within a single system.
Clinical Review and Prescribing
Once a patient completes intake, the clinical review process should be structured and efficient:
- AI-assisted screening flags contraindications, summarizes medical history, and prepares a clinical summary for physician review
- Physician review of the clinical summary, intake data, and any lab results
- Clinical decision to approve, request additional information, or decline
- Prescription creation with appropriate peptide, dosing, route of administration, and treatment duration
- Pharmacy routing to send the prescription directly to the compounding pharmacy
The goal is to minimize the physician’s time on administrative tasks while maintaining full clinical control. AI-assisted clinical review can reduce the per-patient review time from 15 to 20 minutes down to 5 minutes or less.
Follow-Up and Monitoring
Peptide therapy patients require ongoing monitoring:
- Check-in schedules at 2 weeks, 4 weeks, and then monthly depending on the protocol
- Treatment adjustments based on patient response and any side effects
- Refill management to ensure patients stay on protocol without gaps
- Reactivation outreach for patients who fall off their treatment schedule
Automated follow-up systems handle much of this. Treatment reminders, check-in prompts, and reactivation campaigns can run automatically, keeping patients engaged without requiring manual outreach from your team.
Compliance and Regulatory Considerations
Peptide therapy sits at the intersection of compounding law, state prescribing regulations, and evolving FDA policy. Getting compliance right is not optional.
Federal Regulatory Status
The FDA categorizes bulk drug substances for compounding eligibility. Category 1 substances can be compounded; Category 2 substances cannot. Before prescribing any peptide, verify its current FDA category status on the FDA’s compounding page. Classifications change and your pharmacy partner should be your first source for current status.
State-Level Requirements
Peptide prescribing regulations vary by state. Check with your state medical board on:
- Prescriptive authority for compounded medications
- Telehealth prescribing rules if you plan to offer virtual consultations
- Any state-specific compounding regulations
- Documentation and record-keeping requirements
Informed Consent
Your informed consent for peptide therapy should clearly state that:
- Many peptide applications are used off-label and are not FDA-approved for the specific condition being treated
- Potential side effects specific to the prescribed peptide
- The expected treatment timeline and what results to anticipate
- The patient’s right to decline treatment or discontinue at any time
Malpractice Coverage
Contact your malpractice insurance provider before launching. Confirm that your policy covers prescribing compounded peptides and any telehealth consultations you plan to offer. Some carriers require a rider or have specific documentation requirements.
Marketing Your Peptide Program to Patients
A peptide program with no patients is just a cost center. Here is how to generate patient demand.
Your Practice Website
Your website is the foundation. You need:
- A dedicated peptide therapy page explaining what you offer, which compounds are available, and what patients can expect
- Patient intake forms embedded directly on the page
- Clear calls to action to schedule a consultation or fill out an intake form
- Educational content about specific peptides (this builds SEO authority and attracts organic traffic)
Patient Education
Patients searching for peptide therapy are typically more educated and research-oriented than average. Create content that speaks to them:
- Blog posts explaining specific peptides and their uses
- FAQ pages addressing common questions about peptide therapy
- Educational emails for your existing patient list
Existing Patient Base
Your current patients are your easiest conversion opportunity. If you already have patients coming in for other services, peptide therapy is a natural upsell:
- Email your existing patients about your new peptide program
- Mention peptide therapy during relevant appointments
- Create referral incentives for patients who send friends and family
Local SEO
Optimize for local search terms like “peptide therapy [your city]” and “Sermorelin prescriber near me.” Google Business Profile, local citations, and location-specific website content help you appear in local search results.
How Karpa Health Supports Your Peptide Program
Karpa Health handles the operational infrastructure so you can focus on clinical care. The platform includes:
- White-label patient intake that embeds on your practice website under your brand
- AI-powered clinical review that screens patients, flags contraindications, and prepares clinical summaries
- One-click prescribing to integrated compounding pharmacies
- Real-time order tracking and direct-to-patient fulfillment
- Automated patient follow-up with treatment reminders and reactivation campaigns
- Built-in telehealth video conferencing and calendar scheduling
Book a call with Karpa Health to see how the platform works for your practice.
For more context on related topics, read guide to adding peptide therapy to your practice and telehealth peptide prescribing guide.
